Botulinum toxin

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

Retrieved on: 
Tuesday, March 29, 2022
Virology, Treatment, Placebo-controlled study, LinkedIn, Safety, Randomness, EEMEA, Gastroenterology, Lidocaine, Skin care, Neuroscience, Grimaldi Forum, CET, Plastic, Elective surgery, AbbVie, Health, Botulinum toxin, Industry, Hyaluronic acid, Face, Masseter muscle, Twitter, Salle, AMI, Beauty, Future, YouTube, Education, Instagram, Facing the Future School, Patient, Pharmaceutical industry, Facebook

IRVINE, Calif., March 29, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, will join industry colleagues and healthcare providers from around the globe for the 20th edition of AMWC in Monaco, France.

Key Points: 
  • The hybrid meeting will be held at Grimaldi Forum, Monaco March 31, 2022 April 2, 2022.
  • Allergan Aesthetics will provide a range of in-person and virtual training packages to support appropriate medical professionals who wish to offer HArmonyCa with Lidocaine to their patients across Europe and in select EEMEA countries.
  • Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
  • AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

Retrieved on: 
Tuesday, March 29, 2022
Virology, Treatment, Placebo-controlled study, LinkedIn, Safety, Randomness, EEMEA, Gastroenterology, Lidocaine, Skin care, Neuroscience, Grimaldi Forum, CET, Plastic, Elective surgery, AbbVie, Health, Botulinum toxin, Industry, Hyaluronic acid, Face, Masseter muscle, Twitter, Salle, AMI, Beauty, Future, YouTube, Education, Instagram, Facing the Future School, Patient, Pharmaceutical industry, Facebook

IRVINE, Calif., March 29, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, will join industry colleagues and healthcare providers from around the globe for the 20th edition of AMWC in Monaco, France.

Key Points: 
  • The hybrid meeting will be held at Grimaldi Forum, Monaco March 31, 2022 April 2, 2022.
  • Allergan Aesthetics will provide a range of in-person and virtual training packages to support appropriate medical professionals who wish to offer HArmonyCa with Lidocaine to their patients across Europe and in select EEMEA countries.
  • Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
  • AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Global Botulinum Toxin Market Forecast to 2028 - by Product Type, Application, and End User - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 16, 2022
Health, Biotechnology, Consensus, People, Association, Injection, Time, Neurotoxin, Health care, Society, Consensus decision-making, Male, International Society, BTX, ASPS, Muscle, COVID-19, Overactive bladder, Patient safety, Migraine, CAGR, Paralysis, ANN, Female, Clostridium botulinum, Growth, Plastic, Industry, Spasticity, Bacteria, Hyperhidrosis, American Society of Plastic Surgeons, American Society for Aesthetic Plastic Surgery, Canning, Dentistry, Marketing, Botulinum toxin

The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.
  • The botulinum toxin market is expected to reach US$ 8,977.62 million by 2028 from US$ 5,307.71 million in 2021.
  • The factors responsible for the botulinum toxin market's growth are increasing aesthetic procedures and the use of botulinum toxin, and the rising number of non-invasive cosmetic procedures.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.

LASER CENTER OF MARYLAND: NEW LOCATION ANNOUNCED

Retrieved on: 
Monday, February 21, 2022
Partnership, Studio, Botulinum toxin, Man, Nursing, Market Court (Sweden), Woman, Medicine, Skin, Patient, BBL, Solution, Beauty salon, Dentistry, Hospital

The new office launch and a partnership with Studio 107 Hair Salon provides a large selection of Laser Center of Maryland's offerings to a new customer base.

Key Points: 
  • The new office launch and a partnership with Studio 107 Hair Salon provides a large selection of Laser Center of Maryland's offerings to a new customer base.
  • The operation of this satellite location maintains Laser Center of Maryland's mission to provide a range of cosmetic, non-surgical, and non-invasive solutions for both men and women in the Maryland area.
  • To celebrate the grand opening of the new office, the Laser Center of Maryland is hosting an open house on March 3rd from 3:00 7:00 p.m. at 107 Market Court, Stevensville, Maryland.
  • Information about Laser Center of Maryland, including all the details for the opening of their new aesthetic medical office in Stevensville, is available at https://lasercentermd.com .

RealSelf Unveils Most-Loved Aesthetic Procedures, According to RealSelf Consumer Worth It Ratings

Retrieved on: 
Thursday, January 27, 2022
News, Motiva, Your Money's Worth, Implant failure, Chin, Woman, Multimedia, Time, View, Skin, Breast, Feedback, Breast augmentation, Neck, Patient, Most, Pinterest, Dentistry, Cosmetics, Birth control, Online shopping, Botulinum toxin, Facebook, RealSelf, Instagram

The comprehensive list of the Most Worth It Honorees1 is determined by Worth It Ratings from real patients on RealSelf from January 1, 2021, to December 31, 2021.

Key Points: 
  • The comprehensive list of the Most Worth It Honorees1 is determined by Worth It Ratings from real patients on RealSelf from January 1, 2021, to December 31, 2021.
  • The RealSelf Worth It Rating is a proprietary consumer satisfaction score based on reviews from consumers on RealSelf who, after undergoing a treatment, rated it as "Worth It" or "Not Worth It."
  • RealSelf announced the 2022 Most Worth It Honorees - the year's most-loved aesthetic procedures.
  • Motiva breast implants (96% Worth It) and Mentor breast implants (96% Worth It) were the top-rated implant brands among RealSelf community members.

Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)

Retrieved on: 
Monday, January 24, 2022
Face, Patient, Virology, Elective surgery, India Reloaded: Inside India's Resurgent Consumer Market, LinkedIn, Breast milk, Myasthenia gravis, Muscle, Dizziness, Allergy, Skin care, Skin infection, Gastroenterology, Human, Wheeze, Xerostomia, AbbVie, NYSE, Rash, Catherine Disher, Digital, Injection, Toxin (comics), Fatigue, Instagram, Headache, Neck pain, Health, Time, Eyebrow, Pain, Vitamin, Eyelid, Plastic, ALS, Education, YouTube, Multimedia, Neuroscience, Asthma, Severe cognitive impairment, Risk, ABBV, Twitter, Weakness, Lambert–Eaton myasthenic syndrome, Medication, Senior, Social media, Birth control, Canning, Pharmaceutical industry, Cosmetics, Botulinum toxin, Facebook

IRVINE, Calif., Jan. 24, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX Cosmetic Story.

Key Points: 
  • IRVINE, Calif., Jan. 24, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX Cosmetic Story.
  • The BOTOX Cosmetic open casting call starts today and will remain open through March 2022**.
  • Candidates who have never received BOTOX Cosmetic will be assessed by a specialist to determine if they are appropriate for treatment with BOTOX Cosmetic; if appropriate, they will be treated with BOTOX Cosmetic.
  • BOTOX Cosmetic may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of taking BOTOX Cosmetic.

Turn Back the Clock with Curated Medical Botox Treatments at Scottsdale’s Number One Medical Spa

Retrieved on: 
Wednesday, January 5, 2022
Online, Face, Filler (animal food), Forehead, Hyperhidrosis, Neck, Goal, Migraine, Life, Trust, DNP, Mouth, Toxin (comics), Katie, Woman, PDO, GLOBE, Cherry, Man, Perspiration, Risk management, Deoxycholic acid, Botulinum toxin

Look no further than Botox and Fillers By Curated Medical Scottsdale, Arizonas number one medical spa, offering a luxury aesthetic and anti-aging experience.

Key Points: 
  • Look no further than Botox and Fillers By Curated Medical Scottsdale, Arizonas number one medical spa, offering a luxury aesthetic and anti-aging experience.
  • Created by Katie Mann, DNP, FNP-C, Curated Medical is proud to offer the highest quality aesthetic treatments, including Botox and Fillers , in Scottsdale and surrounding areas.
  • Botox and Fillers By Curated Medical is proud to offer Botox (onabotulinumtoxinA), one of the worlds most popular injectable anti-aging treatments.
  • Located in a state-of-the-art facility, Curated Medical is the number one medical spa in Scottsdale, Arizonaoffering modern technologies in a luxurious spa environmentwith top-of-the-line amenities.

Optima Dermatology to Open in Exeter, NH

Retrieved on: 
Tuesday, January 4, 2022
Dermatitis, Family, Acne, View, Optima, Dermatology, Growth, Health, Patient, ME, Learning, Skin cancer, Psoriasis, Multimedia, FAAD, Skin care, Friends, Johns Hopkins School of Medicine, Hospital, Veterinary medicine, Botulinum toxin

Optima Dermatology looks forward to serving patients in Exeter and the surrounding communities and is proud to bring its mission of creating greater access to expert dermatology care to the region.

Key Points: 
  • Optima Dermatology looks forward to serving patients in Exeter and the surrounding communities and is proud to bring its mission of creating greater access to expert dermatology care to the region.
  • Optima Dermatology's industry-leading, board-certified dermatologists and providers treat a broad range of medical dermatology conditions and diseases, including skin cancer, eczema, acne, psoriasis, and more.
  • In addition to general dermatology, Optima Dermatology offers medical aesthetic services, including neurotoxin injections (such as Botox and Dysport), fillers, and more.
  • If you are a healthcare provider interested in learning more about Optima Dermatology, please contact our medical community team at [email protected] .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, December 2, 2021
Freedom, News, Review, FOIA, Newsroom, SEC, SAN, Program, City, Person, Freedom of Information Act (Illinois), Twitter, Botulinum toxin, GLOBE, FDA, Steve Berman (lawyer), Therapy, NASDAQ, Medical device, Pharmaceutical industry

SAN FRANCISCO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now .
  • Revance Therapeutics plans to compete in the Botulinum toxin market dominated by Allegans BOTOX.
  • If you invested in Revance Therapeutics and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Wednesday, November 24, 2021
Freedom, News, Review, FOIA, Newsroom, SEC, SAN, Program, City, Person, Freedom of Information Act (Illinois), Twitter, Botulinum toxin, GLOBE, FDA, Steve Berman (lawyer), Therapy, NASDAQ, Pharmaceutical industry, Medical device

SAN FRANCISCO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors with significant losses to submit your losses now .
  • Revance Therapeutics plans to compete in the Botulinum toxin market dominated by Allegans BOTOX.
  • If you invested in Revance Therapeutics and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.